Health
AstraZeneca Says Current, Former Executives Involved in China Probe
- The company’s China president has been detained by authorities
- Astra has attempted to quell concerns over the investigation
The AstraZeneca facility in Gaithersburg, Maryland.
Photographer: Graeme Sloan/BloombergThis article is for subscribers only.
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe into alleged breaches of laws around drug importation and data privacy, the company said.
This is in addition to Leon Wang, the British drugmaker’s China president, who remains in detention, an Astra spokesman told Bloomberg.